These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23837743)

  • 1. CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults.
    Segal AO; Ellis AK; Kim HL
    Allergy Asthma Clin Immunol; 2013 Jul; 9(1):24. PubMed ID: 23837743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
    Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
    BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis.
    Hong CH; Gooderham M; Bissonnette R
    J Cutan Med Surg; 2019; 23(4_suppl):5S-10S. PubMed ID: 31476937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Position statement: topical calcineurin inhibitors in atopic dermatitis.
    Remitz A; De Pità O; Mota A; Serra-Baldrich E; Vakirlis E; Kapp A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2074-2082. PubMed ID: 30288799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.
    Luger T; Boguniewicz M; Carr W; Cork M; Deleuran M; Eichenfield L; Eigenmann P; Fölster-Holst R; Gelmetti C; Gollnick H; Hamelmann E; Hebert AA; Muraro A; Oranje AP; Paller AS; Paul C; Puig L; Ring J; Siegfried E; Spergel JM; Stingl G; Taieb A; Torrelo A; Werfel T; Wahn U
    Pediatr Allergy Immunol; 2015 Jun; 26(4):306-15. PubMed ID: 25557211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC; Qureshi AA
    Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Munzenberger PJ; Montejo JM
    Pharmacotherapy; 2007 Jul; 27(7):1020-8. PubMed ID: 17594208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of atopic eczema.
    Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM
    GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations.
    Carr WW
    Paediatr Drugs; 2013 Aug; 15(4):303-10. PubMed ID: 23549982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Role of Topical Calcineurin Inhibitors: A Pediatric Dermatology Perspective.
    Fiorillo L; Marcoux D; Ramien M
    J Cutan Med Surg; 2019; 23(4_suppl):11S-18S. PubMed ID: 31476940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atopic dermatitis: a review of topical nonsteroid therapy.
    Papier A; Strowd LC
    Drugs Context; 2018; 7():212521. PubMed ID: 29632548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis.
    Fröschl B; Arts D; Leopold C
    GMS Health Technol Assess; 2007 Sep; 3():Doc09. PubMed ID: 21289943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is the Risk of Harm Associated With Topical Calcineurin Inhibitors?
    Hanna S; Zip C; Shear NH
    J Cutan Med Surg; 2019; 23(4_suppl):19S-26S. PubMed ID: 31476938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus.
    Luger T; Augustin M; Lambert J; Paul C; Pincelli C; Torrelo A; Vestergaard C; Wahn U; Werfel T
    Pediatr Allergy Immunol; 2021 Apr; 32(3):414-424. PubMed ID: 33251600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
    Kalavala M; Dohil MA
    Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
    Draelos ZD
    Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.